ArticleLeukemia2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.
A M Zeidan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papertrialcites it